Drug Discovery

#Drug discovery #Events #Neuroscience #Webinar

Webinar: The opportunities in neuroscience drug discovery

Hosted by Drug Discovery World and sponsored by Emulate, this free webinar explores where innovation is taking place within neuroscience drug discovery.  The webinar sees experts and leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug… Read More

Webinar date:
Sponsored by Emulate
#News

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Lab technology

The real impact of AI on molecular design

Martin Stumpe, PhD, Chief Data & Artificial Intelligence Officer at Danaher, examines the factors affecting AI’s impact on drug discovery. The artificial intelligence (AI) boom in life sciences has sparked a rush of new technologies to design molecules fit for purpose. The potential is enormous, with promised benefits for both… Read More

#Exclusive Content

Liverpool, UK
#Drug discovery #ELRIG #Events

ELRIG announces keynote speakers for Drug Discovery 2025

ELRIG has revealed the keynote speakers for its flagship event, Drug Discovery 2025, taking place at the ACC in Liverpool, UK from 21-22 October.  The conference will feature presentations from Professor Heather Pinkett of Northwestern University in Illinois, and Dr Dafydd Owen of Pfizer Medicine Design. … Read More

#News

#Drug discovery

Introductory Guide – Unlocking the biopharma development pipeline

Discover a new generation of molecular sensing technology from Oxford Nanopore Technologies that is transforming the biopharma development pipeline.   You’ll explore:    How Oxford Nanopore sequencing overcomes challenges faced in the drug development process    Advantages of a single-platform solution   End-to-end workflows that can be applied to each… Read More

#Guides

Double stranded DNA molecule with mutation in a gene
#Clinical trials #Cystic fibrosis #Drug delivery #Drug development #Europe #Kither Biotech

In Conversation With: Dimitrios Goundis, Kither Biotech

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dimitrios Goundis, CEO… Read More

#News

#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Advancing cardiotoxicity studies with 3D models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

#Animal models #Animal testing #Drug discovery

Drug discovery use-cases with animal models

DDW Editor Reece Armstrong takes a look at three pieces of animal model research that are driving forward drug discovery. Animal models have been used as standard tools for clinical research for decades now, helping researchers bring treatments to market. Though the models have faced challenges in translating results seen… Read More

#Exclusive Content

#Antibodies #Cell analysis #Cell therapy #Drug discovery #Single-cell analysis

How real-time analysis of single cells can advance drug discovery  

DDW Editor Reece Armstrong speaks to Vikram Devgan, PhD, VP of Global Marketing and Product Management, Bruker Cellular Analysis, about how real-time access to single cells can drive functional insights.   RA: How has single-cell research evolved over the past two decades?  VD: Single-cell… Read More

#Exclusive Content

#Biotechnology #Drug development #MoonLake #Nanobodies

Meet the researcher: Kristian Reich

DDW’s Megan Thomas looks at a day in the life of Professor Kristian Reich, Co-Founder and CSO of MoonLake.  MT: Can you tell us what you do and what you’re working on at the moment? KR: As Co-Founder and Chief Scientific Officer of MoonLake, an advancing biotechnology company without the… Read More

#Exclusive Content

#Drug discovery #Events #Neuroscience #Webinar

Webinar: Where is the innovation in neuroscience drug discovery?

Hosted by Drug Discovery World and sponsored by Emulate, this free webinar explores where innovation is taking place within neuroscience drug discovery.  The webinar sees experts and leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug… Read More

Webinar date:
Sponsored by Emulate
#News

#bit bio #CAR-T #CRISPR #Drug development #Drug discovery #Stem cells #Synthetic biology #Synthetic DNA

New podcast: An overview on the impact of synthetic biology

This is the latest episode of the free DDW narrated podcast, titled “An overview on the impact of synthetic biology”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Synthetic biology: Impacting drug discovery” and “Synthetic biology: Innovating in drug… Read More

#News

Heart
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: Cardiac screening with physiologically relevant 3D models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News

AI concept
#Artificial intelligence (AI) #Contract Research Organisations (CROs) #Drug discovery

AI in drug discovery: Separating hype from reality, and what it holds for CROs

Dr Kenneth Barr, Senior Vice President, Discovery Services at Syngene International, examines the reality of using AI in drug discovery and its relevance for CROs. In an industry where investments are huge, the time to market is over a decade, and success rates hover around 10%, technological advances that significantly… Read More

#Business & Investment #Exclusive Content

Cardiovascular system
#3D modelling #Cell Science #Drug discovery #Drug toxicity #High throughput screening #Screening #Webinar

Webinar: How can 3D cardiac models advance drug screening?

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in… Read More

Webinar date:
Supported by Ncardia
#News